For the Inventor, By the Inventor

Enter assignee name

Allschwil, Switzerland

Polyphor Ltd.

USPTO Granted Patents = 28

CIPO Patents = 3

EPO Patents = 8

Forward Citations = 175

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Daniel Obrecht (28 out of 67 patents)

Frank Gombert (25 out of 29 patents)

Christian Ludin (20 out of 26 patents)

4. Steven J Demarco (18 out of 19 patents)

5. Jan Wim Vrijbloed (16 out of 17 patents)

6. Heiko Henze (15 out of 15 patents)

7. Kerstin Moehle (13 out of 15 patents)

8. Barbara Romagnoli (13 out of 21 patents)

9. Reshmi Mukherjee (12 out of 13 patents)

10. John Anthony Robinson (12 out of 22 patents)

11. John-Anthony Robinson (7 out of 7 patents)

12. Wim Vrijbloed (5 out of 5 patents)

13. Ricardo Dias (5 out of 5 patents)

14. Nityakalyani Srinivas (5 out of 5 patents)

15. Odile Sellier (4 out of 4 patents)

28 patents: Sort by Forward Citations

1. 11421001 - Template-fixed peptidomimetics (2022-08-23),

2. 10787486 - Template-fixed peptidomimetics (2020-09-29),

3. 10730912 - Template-fixed peptidomimetics with antimicrobial activity (2020-08-04),

4. 10562933 - Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity (2020-02-18),

5. 10144765 - Template-fixed peptidomimetics (2018-12-04),

6. 10100084 - Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity (2018-10-16),

7. 10000535 - Template-fixed peptidomimetics (2018-06-19),

8. 9879047 - Template-fixed peptidomimetics (2018-01-30),

9. 9596852 - Template-fixed peptidomimetics with antimicrobial activity (2017-03-21),

10. 9556234 - Template-fixed peptidomimetics (2017-01-31),

11. 9538752 - Template-fixed peptidomimetics with antimicrobial activity (2017-01-10),

12. 9521846 - Template-fixed peptidomimetics with antimicrobial activity (2016-12-20),

13. 9518092 - Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity (2016-12-13),

14. 9073973 - Dye conjugates of template-fixed peptidomimetics (2015-07-07),

15. 8921325 - Template-fixed peptidomimetics (2014-12-30),

Polyphor is a clinical stage, Swiss biopharmaceutical company focused on the discovery and development of innovative antibiotics and immuno-oncology drugs. With its innovative macrocycle drug discovery platform, Polyphor is recognized as a leader in the development of antibiotics against multi-drug resistant Gram-negative bacteria. The company's pipeline includes potential first-in-class antibiotics, including an inhaled formulation being developed for the treatment of cystic fibrosis.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

28 Patents

#5 in Allschwil

#448 in Switzerland

#22,553 in the World

Allschwil, Switzerland

Polyphor Ltd.

Forward Citations = 175

28 inventors:

Daniel Obrecht (28 out of 67 patents)

Frank Gombert (25 out of 29 patents)

Christian Ludin (20 out of 26 patents)

4. Steven J Demarco (18 out of 19 patents)

5. Jan Wim Vrijbloed (16 out of 17 patents)

Please report any incorrect information to support@idiyas.com

Loading…